IL6 and COVID-19: Previous studies suggest that both OSA and COVID-19 increase the expression of several inflammatory stress, including proinflammatory cytokines as IL-6, developing an endothelial vulnerability, and therefore, increasing the permeability of this markers to the brain (38).